Psychiatry & Neurology, Geriatric Psychiatry · Providence, RI
NPI
1629082458
Since 2006
Specialty
Psychiatry & Neurology, Geriatric Psychiatry
Code 2084P0805X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
42 General St
Providence, RI, 02904
Phone (401) 270-4649
Medicare paid, 2024
$300K
1,410 services
Medicare patients, 2024
196
Average age 76
Drug cost, 2024
$2.6M
14,181 prescriptions
Company payments, 2025
$992
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert Kohn was code 90833 (psychotherapy - nongroup), 525 times for 139 patients. In total Robert Kohn billed 1,410 services in 12 codes, and Medicare paid $300K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90833 Psychotherapy - Nongroup | Office | 525 | 139 | $55.18 | $29K |
| 99214 Office E&M - Established | Office | 513 | 139 | $94.78 | $49K |
| 99350 Home E&M - New and Established | Office | 73 | 36 | $136.73 | $9,981 |
| 99349 Home E&M - New and Established | Office | 39 | 19 | $84.91 | $3,312 |
| 90792 Psychotherapy - Nongroup | Office | 25 | 25 | $136.69 | $3,417 |
By year: 2022 $222K for 1,800 services; 2023 $230K for 1,526 services; 2024 $300K for 1,410 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert Kohn prescribed most often to Medicare patients was Clonazepam, with 1,215 prescriptions and refills. In total Robert Kohn wrote 14,181 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 1,215 | 1,311 | 159 | $14K |
| Bupropion Xl Bupropion Hcl | 793 | 1,407 | 115 | $17K |
| Quetiapine Fumarate Generic | 776 | 1,138 | 126 | $13K |
| Sertraline Hcl Generic | 748 | 1,185 | 126 | $14K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 727 | 1,256 | 96 | $14K |
| Trazodone Hcl Generic | 682 | 1,055 | 115 | $7,188 |
| Mirtazapine Generic | 647 | 1,110 | 126 | $13K |
| Aripiprazole Generic | 571 | 882 | 101 | $29K |
| Spravato Esketamine Hcl | 523 | 523 | 12 | $640K |
| Lorazepam Generic | 518 | 544 | 84 | $4,941 |
| Duloxetine Hcl Generic | 478 | 834 | 83 | $12K |
| Donepezil Hcl Generic | 467 | 812 | 92 | $5,589 |
| Alprazolam Generic | 413 | 456 | 56 | $3,525 |
| Quetiapine Fumarate Er Quetiapine Fumarate | 338 | 446 | 47 | $22K |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 321 | 321 | 35 | $12K |
Brand drugs: 1,053 claims; generic drugs: 13,128 claims; opioid claims: 92.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert Kohn $992 ($992 in general payments such as food, travel and fees) from 9 companies. The largest payer was Janssen Scientific Affairs, LLC with $200.
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC JNJ | 1 | $200 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $168 |
| Abbvie Inc. ABBV | 7 | $136 |
| Neurocrine BioSciences, Inc. NBIX | 6 | $129 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $118 |
| Lundbeck LLC | 6 | $113 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $93.32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $18.9 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $16.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.